Kestra Private Wealth Services’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Kestra Private Wealth Services’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-581	Closed	-$17K	–	1042
2021 Q3	$17K	Sell	581 -470	-45%	-$13.3K	﹤0.01%	919
2021 Q2	$35K	Sell	1,051 -200	-16%	-$7.45K	﹤0.01%	877
2021 Q1	$52K	Sell	1,251 -156	-11%	-$9.69K	﹤0.01%	790
2020 Q4	$88K	Sell	1,407 -1,168	-45%	-$127K	0.01%	716
2020 Q3	$343K	Buy	+2,575	New	+$430K	0.03%	463

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Kestra Private Wealth Services's NBRV Position: Q4 2021 in Review

Kestra Private Wealth Services sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2021, closing a stake of 581 shares — an estimated $17K sold.

Kestra Private Wealth Services first reported a position in NBRV in Q3 2020 and held it in 5 quarters. The position peaked at $343K in Q3 2020. 34 funds tracked by Wall St. Rank hold NBRV as of Q4 2021.

Kestra Private Wealth Services reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2021 after selling out during the quarter.
Kestra Private Wealth Services sold 581 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2021, an estimated $17K.
Kestra Private Wealth Services first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2020 and held it in 5 quarters.
Kestra Private Wealth Services's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $343K in Q3 2020.
34 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2021.

Based on Kestra Private Wealth Services's 13F filing for Q4 2021, filed 21 Jan 2022.